Biotechnology - Management

Filter

Current filters:

Management

Popular Filters

1 to 25 of 44 results

NicOx launches commercial operations in Germany

30-06-2014

Ophthalmology-focused French biotech firm NicOx has today announced the launch of its German operations.

AdenoPlusBiotechnologyGermanyManagementMarkets & MarketingNicOxOphthalmicsXailin

Affymax decides to wind up company following demise of Omontys

Affymax decides to wind up company following demise of Omontys

25-06-2014

USA-based biotech firm Affymax says that its board of directors has approved the liquidation and dissolution…

AffymaxBiotechnologyFinancialManagementOmontysOncologyTakeda Pharmaceutical

ThromboGenics plans to remain independent

24-06-2014

In response to market rumors, Belgian biotech firm ThromboGenics today issues an update on the Strategic…

BiotechnologyJetreaManagementOphthalmicsThromboGenics

Big pharma becomes a smaller employer while biotech booms

Big pharma becomes a smaller employer while biotech booms

19-06-2014

Big pharma employment dropped by 3% in the decade 2003-2013, allaying fears that industry consolidation…

BiotechnologyManagementPharmaceutical

Dendreon chief to step down for personal reasons

Dendreon chief to step down for personal reasons

10-06-2014

US biotech firm Dendreon revealed last evening that John Johnson plans to step down as president and…

BiotechnologyBoardroomDendreonManagementProvenge

Biota Pharma plans restructuring following loss of BARDA contract

02-06-2014

USA-based Biota Pharmaceuticals has adopted a plan to restructure the company's operations following…

Anti-viralsBiota PharmaceuticalsBiotechnologyFinanciallaninamivirManagementUSA

China Summit paves the way for Australian companies, says AusBiotech

China Summit paves the way for Australian companies, says AusBiotech

11-03-2014

Recognizing the leading role China will take globally in the future of life sciences, trade group AusBiotech…

Asia-PacificAustraliaBiotechnologyChinaManagementResearch

Merck names Simon Sturge as new head of biosimilars unit

Merck names Simon Sturge as new head of biosimilars unit

20-02-2014

Germany’s Merck KGaA has appointed Simon Sturge to head the biosimilars unit, effective March 1, succeeding…

BiosimilarsBiotechnologyBoardroomManagementMerck KGaA

Domain Therapeutics opens North American subsidiary

20-01-2014

French biopharma company Domain Therapeutics, specializing in the R&D of new drug candidates targeting…

BiotechnologyCanadaDomain TherapeuticsManagementNorth America

Agilis Biotherapeutics and Intrexon collaborate on rare genetic disease

01-01-2014

US synthetic biology companies Agilis Biotherapeutics and Intrexon have entered an exclusive channel…

Agilis BiotherapeuticsBiotechnologyBoardroomFinancialIntrexonManagementRare diseasesResearch

AVEO Oncology restructuring and job cuts as tivozanib future in RCC in doubt

05-06-2013

Following a recent negative opinion on its lead product candidate from a Food and Drug Administration…

Astellas PharmaAVEO OncologyBiotechnologyFinancialManagementOncologyResearchtivozanib

Exec appointments at Biogen Idec and Halozyme; Succession plan for Forest Labs

23-05-2013

US biotech firm Biogen Idec (Nasdaq: BIIB) announced that Spyros Artavanis-Tsakonas, has been named chief…

Biogen IdecBiotechnologyForest LaboratoriesHalozyme TherapeuticsManagementPharmaceutical

US Senate confirms appointment of Marilyn Tavenner as CMS Administrator

16-05-2013

US Health and Human Services (HHS) Secretary Kathleen Sebelius announced that the US Senate has confirmed…

BiotechnologyGenericsHealthcareManagementNorth AmericaPharmaceutical

Aastrom Biosciences to re-focus on DCM program, and cut workforce

28-03-2013

US cardiovascular drug developer Aastrom Biosciences (NasdaqCM: ASTM) has announced a strategic change…

Aastrom BiosciencesBiotechnologyCardio-vascularixmyelocel-TManagementResearch

Affymax slashes workforce following Omontys problems; evaluating options

19-03-2013

US biopharma company Affymax (Nasdaq: AFFY) says that it will reduce its workforce as part of a plan…

AffymaxBiotechnologyFinancialManagementOmontysOncologyPharmaceutical

CoCo Therapeutics created in UK to progress retinoic acid receptor alpha agonist for Alzheimer's

07-03-2013

King's College London, The Wellcome Trust and Advent Venture Partners have announced the formation of…

BiotechnologyCoCo TherapeuticsFinancialManagementResearch

Roche granted EU approval for Perjeta; board appointments

06-03-2013

The European Medicines Agency has approved Swiss drug major Roche's (ROG: SIX) Perjeta (pertuzumab) for…

BiotechnologyEuropeManagementOncologyPerjetaPharmaceuticalRegulationRoche

New US Federal Trade Commission chairman - Edith Ramirez - to be designated by President

03-03-2013

President Barack Obama intends to designate Edith Ramirez as Chairman of the Federal Trade Commission…

BiotechnologyGenericsManagementNorth AmericaPharmaceuticalRegulation

Biopharma facing hiring difficulties and R&D talent gap, PwC unit finds

04-02-2013

A talent gap in the scientific workforce has biopharmaceutical companies searching outside for fresh…

BiotechnologyManagementNorth AmericaPharmaceuticalResearch

BioCryst Pharma restructures in face of pipeline disappointments

10-12-2012

USA-based BioCryst Pharmaceuticals (Nasdaq: BCRX), whose merger with Presidio was called off earlier…

BCX4161BCX5191BioCryst PharmaceuticalsBiotechnologyFinancialManagementperamivirResearchulodesine

Drugmakers spend an average $237,000 per medical science liaison in the USA

31-10-2012

US-based drug companies spend an average $237,000 on each of their medical science liaisons (MSLs), but…

BiotechnologyGlobalManagementMarkets & MarketingPharmaceutical

The way forward in health care, by Gilbert Mertens

28-10-2012

Preparing for a future of unseen opportunity in health care requires a profound shift in thinking from…

BiotechnologyHealthcareManagementPharmaceuticalResearch

1 to 25 of 44 results

Back to top